focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Regulatory News (USA)

Share Price Information for Baillie Gifford (USA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.40
Bid: 196.40
Ask: 197.00
Change: -1.20 (-0.61%)
Spread: 0.60 (0.305%)
Open: 200.00
High: 200.00
Low: 196.40
Prev. Close: 197.60
USA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Baillie Gifford US Growth Trust: Investing in the rapidly approaching future

25 Sep 2023 09:05

Edison Investment Research Limited Baillie Gifford US Growth Trust: Investing in the rapidly approaching future 25-Sep-2023 / 09:04 GMT/BST The issuer is solely responsible for the content of this announcement.


 

London, UK, 25 September 2023

 

Baillie Gifford US Growth Trust: Investing in the rapidly approaching future

The managers of Baillie Gifford US Growth Trust (USA), Gary Robinson and Kirsty Gibson, aim to invest in exceptional US businesses with the potential to grow substantially faster than the market and deliver exceptional returns over the long term. Businesses capable of such growth tend to operate at the cutting edge of technology-led change, and USA has exposure to companies focused on artificial intelligence, space travel and drone delivery. The fluctuating fortunes of growth stocks over the past couple of years, combined with some de-rating of USA’s unlisted holdings, mean that USA’s performance has undershot market returns during the first five years since inception. Cumulative returns over the five years ended August 2023 totalled 49.1% in NAV terms, lagging the market return of 73.8%. However, the managers believe the ‘phenomenal’ fundamental performance of many portfolio holdings, combined with their very good growth prospects, augur well for the company’s ability to realise its return target over the longer term.

 

Baillie Gifford’s reputation as a long-term, patient investor in the US and in private companies gives USA’s managers the ability to access exciting unlisted opportunities, arguably a significant competitive advantage.

Viewed from a risk management perspective, an investment in USA can, arguably, be seen as offering investors insurance against a world that is changing far more quickly that traditional risk models acknowledge.

USA’s historically wide discount may offer investors the opportunity to gain exposure at a potentially attractive level.

 

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached – across institutions, family offices, wealth managers and retail investors – Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Joanne Collins +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1733469 25-Sep-2023 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
17th May 202411:50 amRNSNet Asset Value(s)
16th May 20245:03 pmRNSTransaction in Own Shares
16th May 20241:45 pmRNSNet Asset Value(s)
15th May 202411:39 amRNSNet Asset Value(s)
14th May 202411:57 amRNSNet Asset Value(s)
13th May 202411:59 amRNSNet Asset Value(s)
10th May 202412:22 pmRNSNet Asset Value(s)
9th May 202412:02 pmRNSNet Asset Value(s)
8th May 202412:09 pmRNSNet Asset Value(s)
7th May 202412:34 pmRNSNet Asset Value(s)
7th May 202411:29 amRNSNet Asset Value(s)
3rd May 20245:15 pmRNSTransaction in Own Shares
3rd May 202412:43 pmRNSNet Asset Value(s)
2nd May 202411:03 amRNSNet Asset Value(s)
1st May 20243:39 pmRNSNet Asset Value(s)
1st May 202410:32 amRNSTotal Voting Rights
30th Apr 202412:00 pmRNSNet Asset Value(s)
29th Apr 202412:34 pmRNSNet Asset Value(s)
26th Apr 202411:46 amRNSNet Asset Value(s)
25th Apr 202411:47 amRNSNet Asset Value(s)
24th Apr 20241:07 pmRNSNet Asset Value(s)
23rd Apr 202411:56 amRNSNet Asset Value(s)
22nd Apr 202412:13 pmRNSNet Asset Value(s)
19th Apr 20244:57 pmRNSTransaction in Own Shares
19th Apr 202412:41 pmRNSNet Asset Value(s)
18th Apr 20243:54 pmRNSHolding(s) in Company
18th Apr 202411:36 amRNSNet Asset Value(s)
17th Apr 202412:07 pmRNSNet Asset Value(s)
16th Apr 20244:02 pmRNSNet Asset Value(s)
15th Apr 202411:27 amRNSNet Asset Value(s)
12th Apr 20245:08 pmRNSTransaction in Own Shares
12th Apr 202411:52 amRNSNet Asset Value(s)
11th Apr 202411:19 amRNSNet Asset Value(s)
10th Apr 202412:46 pmRNSNet Asset Value(s)
9th Apr 202411:28 amRNSNet Asset Value(s)
8th Apr 202411:34 amRNSNet Asset Value(s)
5th Apr 202411:19 amRNSNet Asset Value(s)
4th Apr 202412:20 pmRNSNet Asset Value(s)
3rd Apr 202411:23 amRNSNet Asset Value(s)
2nd Apr 20244:35 pmRNSNet Asset Value(s)
2nd Apr 20243:54 pmRNSNet Asset Value(s)
2nd Apr 20241:35 pmRNSNet Asset Value(s)
2nd Apr 202411:52 amRNSTotal Voting Rights
28th Mar 202412:11 pmRNSNet Asset Value(s)
27th Mar 202412:05 pmRNSNet Asset Value(s)
26th Mar 20244:57 pmRNSTransaction in Own Shares
26th Mar 202412:05 pmRNSNet Asset Value(s)
25th Mar 202412:29 pmRNSNet Asset Value(s)
25th Mar 202411:56 amRNSBlock listing Interim Review
22nd Mar 202412:09 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.